SterRx, LLC: Drug Recall
Recall #D-0932-2023 · 07/07/2023
Class II: Risk
Recall Details
- Recall Number
- D-0932-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- SterRx, LLC
- Status
- Terminated
- Date Initiated
- 07/07/2023
- Location
- Plattsburgh, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 125,598 bags
Reason for Recall
Lack of Assurance of Sterility
Product Description
Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-577-01.
Distribution Pattern
Nationwide in the USA
Other Recalls by SterRx, LLC
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
- Class II: Risk 07/07/2023
- Class II: Risk 07/25/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.